Endoprost 250 Injection
Regulated Product — Business License RequiredB2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.
Product Overview
Endoprost 250 Injection contains carboprost, a prostaglandin. Its labelling describes it for the control of excessive bleeding after childbirth (postpartum haemorrhage) by promoting contraction of the uterine muscles. It is described as given only under the strict supervision of a medical professional in a hospital setting, only after delivery and never during pregnancy.
Product Information
The following description reflects information associated with carboprost (a prostaglandin) and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.
Described Uses
- Described for the control of excessive bleeding after childbirth (postpartum haemorrhage)
- Described as promoting contraction of the uterine muscles to reduce bleeding
- Described as given only after delivery and never during pregnancy
Described Dosage & Administration
- Given only by a doctor as an injection in a hospital setting — not self-administered and not given outside a hospital
- The doctor sets the dose and any repeat doses according to the clinical situation
- Given only after delivery, never during pregnancy
Described Side Effects
Commonly described side effects include:
- Nausea and vomiting
- Headache
- Flushing and hot flushes
- Diarrhoea
- Chills
- Retained placenta
- Cough
These are described as completely temporary; the doctor should be consulted if any effect persists for more than a day. Any severe, persistent, or unexpected reaction requires prompt medical attention.
Precautions
- The medicine is described as causing dizziness, so driving and tasks needing full attention should be avoided
- The doctor should be told about any history of heart, liver, or kidney disease, and about high or low blood pressure
- A full medication history, including any ongoing medicines, should be shared with the doctor
- It is given only after delivery and never during pregnancy
This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.
B2B, Import & Export Enquiries
SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.
We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.
Request Product Information
Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.
Frequently Asked Questions
Per its labelling it contains carboprost, a prostaglandin used to control excessive bleeding after childbirth by promoting contraction of the uterine muscles. It is given only after delivery and never during pregnancy. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.
Its labelling states it is given only by a doctor as an injection in a hospital setting, under strict medical supervision. It is not self-administered and is not given outside a hospital.
Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.
Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.
Related Product Categories
SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.